Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2004
10/19/2004US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists
10/19/2004CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/14/2004WO2004087700A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
10/14/2004WO2004087663A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/14/2004WO2004087662A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
10/14/2004WO2004087661A1 Process for the enantioselective production of an amino acid derivative comprising at least one nitrogenous heterocycle
10/14/2004WO2004087660A1 A novel process for amorphous form of donepezil hydrochloride
10/14/2004WO2004087659A1 Chemical compounds
10/14/2004WO2004087656A1 Conjugates of 2,4-ethano-bridged and 2,4-propano-bridged 3,6,9-triaza-nonanoic acid, 3n,6n,9,9n-tetraethanoic acid, and corresponding phosphoric acid methylene derivatives and the substitution products thereof with biomolecules, methods for the production thereof, and the use of the same for produ
10/14/2004WO2004087156A1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
10/14/2004WO2004087155A1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
10/14/2004WO2004087074A2 Process for making substituted pyrazoles
10/14/2004WO2004058700A3 Mitotic kinesin inhibitors
10/14/2004WO2004005256A3 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors
10/14/2004US20040204604 Such as felodipine and nitrendipine, by condensation of an aldehyde and an acetoacetate in the presence of a catalyst system that includes a pyridyl carboxylic acid and a secondary amine; high purity and yield
10/14/2004US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004US20040204460 Sodium channel modulators
10/14/2004US20040204459 Melting point of 150-152 degrees C and 3-4% ethyl acetate; antihypertensive agents
10/14/2004US20040204457 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
10/14/2004US20040204456 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
10/14/2004US20040204455 For therapy of hypertension, and congestive heart failure
10/14/2004US20040204453 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders
10/14/2004US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders
10/14/2004US20040204398 Acylated piperazine derivatives as melanocortin-4 receptor agonists
10/14/2004US20040204369 Novel amide derivatives
10/14/2004DE10315412A1 Preparation of tetramethylpiperid-4-one, by reacting acetone, or its condensation products, with ammonia, in presence of an ionic fluid
10/14/2004CA2521172A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
10/14/2004CA2521073A1 Chemical compounds for the treatment of chemokine mediated disease state
10/14/2004CA2520674A1 Process for making substituted pyrazoles
10/14/2004CA2520493A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/13/2004EP1466971A1 Preparation of lactams from aliphatic alpha,omega dinitriles
10/13/2004EP1466904A1 Biaryl compound and use thereof
10/13/2004EP1466901A1 Serotonine reuptake inhibitor
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1466605A2 Calcium channel blockers
10/13/2004EP1465868A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression
10/13/2004EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465726A1 Process for preparing nonracemic chiral alcohols
10/13/2004EP1465488A1 Arylamines as inhibitors of chemokine binding to us28
10/13/2004EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004EP0986389B1 Novel process
10/13/2004EP0934928B1 Cyclic amine derivatives
10/13/2004EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same
10/13/2004CN1535961A Non-sterioid inflammation-resisting compound
10/13/2004CN1535682A Medicine for improved bladder excretion capacity
10/13/2004CN1170819C Piperidine alcohols
10/13/2004CN1170814C Amide compounds for potentiation of cholinergic activity
10/13/2004CN1170537C Substituted 1-(piperidin-4-yl)3-(aryl)-isothioureas, ther prepn. and therapeutic use
10/07/2004WO2004086050A2 Labelling agents for mass spectrometry comprising tertiary amines
10/07/2004WO2004085431A1 Prostaglandin analogs as ep4 receptor antagonists
10/07/2004WO2004085430A1 Prostaglandin analogs as ep4 receptor agonists
10/07/2004WO2004085397A1 Process for the oxidation of secondary amines into the corresponding nitroxides
10/07/2004WO2004085385A2 Cannabinoid receptor ligands
10/07/2004WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
10/07/2004WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/07/2004WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
10/07/2004WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function
10/07/2004US20040198983 including fexofenadine; novel synthetic intermediate 2-(4-{4-(Hydroxydiphenyl-methyl)-piperidine-1-yl]-4-oxo-butyryl}-phenyl)-2-2-methyl-propionic Acid lower alkyl ester
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004US20040198701 EP4 receptor agonist, compositions and methods thereof
10/07/2004CA2519401A1 Cannabinoid receptor ligands
10/06/2004EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
10/06/2004EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004EP1326832B1 Chemical compounds
10/06/2004EP1181934B1 1,4-dihydropyridine derivatives as inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder
10/06/2004EP1165509B1 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines
10/06/2004EP1135379B1 Antitumor dibenzofluorene derivatives
10/06/2004EP1101755B1 Anthranilic acid derivatives
10/06/2004EP1098864B1 Method for hydrogenating unsaturated heterocyclic compounds
10/06/2004EP0867183B1 Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
10/06/2004CN1534021A Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery
10/06/2004CN1534016A Calcium acceptor active compound
10/05/2004US6800708 Oligomeric and polymeric telechelics
10/05/2004US6800678 Flame retardant compositions
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
10/05/2004US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor
10/05/2004US6800628 Such as (1-(2-((3-methyl-2-pyrazinyl)amino)ethyl)-4-piperidinyl)-methyl-4-amino-5 -chloro-2,3-dihydro-7-benzofurancarboxylate
10/05/2004US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no
10/05/2004CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
09/2004
09/30/2004WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
09/30/2004WO2004083182A1 Cathepsin s inhibitors
09/30/2004WO2004083181A1 Synthesis of aryl-substituted piperidines by hydrogenation of aryl-substituted pyridines
09/30/2004WO2004083170A2 Compounds, a process for their preparation and their use as dyes and pigments
09/30/2004WO2004082685A1 Process for the preparation of donepezil and derivatives thereof
09/30/2004WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity
09/30/2004WO2004082623A2 Substituted piperidine compounds
09/30/2004WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192920 Condensing a suitable alcohol with a piperidone in the presence of polyphosphoric acid.
09/30/2004US20040192919 Cyclization of 2-(3,4-dimethoxybenzyl)-3-(n-benzyl-4-piperidine)propionic acid; salt formation with hydrogen chloride
09/30/2004US20040192783 Use of B-2 bronchodilator drugs
09/30/2004US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide
09/30/2004US20040192703 Preferentially substituted calcium channel blockers
09/30/2004US20040192681 N-acylsulfonamide apoptosis promoters